Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2003; 41:949-954, doi:10.1016/S0735-1097(02)03006-1
© 2003 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by East, M. A.
Right arrow Articles by Peterson, E. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by East, M. A.
Right arrow Articles by Peterson, E. D.

CLINICAL STUDY: RACE, GENDER, AND CAD

The influence of left ventricular hypertrophyon survival in patients with coronaryartery disease: do race and gender matter?

Mark A. East, MD*,*, James G. Jollis, MD, FACC*, Charlotte L. Nelson, MS*, David Marks, MD, FACC{dagger} and Eric D. Peterson, MD, MPH, FACC*

* Outcomes Research and Assessment Group, The Duke Clinical Research Institute, Durham, North Carolina, USA
{dagger} Medical College of Wisconsin, Milwaukee, Wisconsin, USA

Manuscript received September 10, 2001; revised manuscript received April 17, 2002, accepted October 25, 2002.

* Reprint requests and correspondence: Dr. Mark A. East, Duke Clinical Research Institute, P.O. Box 17969, Durham, North Carolina 27715, USA.
east0001{at}onyx.dcri.duke.edu

OBJECTIVES: We sought to determine the overall prognostic importance of left ventricular hypertrophy (LVH) among patients with coronary artery disease (CAD), as well as to determine whether this risk varies as a function of race or gender.

BACKGROUND: Left ventricular hypertrophy is more prevalent among blacks and women than their counterparts. Blacks and women also have higher mortality with coronary disease.

METHODS: We studied records of 2,461 patients (19% black, 42% women) diagnosed with CAD at cardiac catheterization between 1990 and 1998 from a single academic center. Left ventricular hypertrophy was defined using standard echocardiographic measures. Cox proportional hazards models were used for adjusted survival analyses. Mean patient follow-up was three years.

RESULTS: Patients with LVH were older (68 vs. 65 years, p < 0.01), more often women (54% vs. 36%, p < 0.01), and black (25% vs. 16%, p < 0.01), and had higher unadjusted three-year mortality rates than patients without LVH (42% vs. 34%, p < 0.01). Left ventricular hypertrophy remained an independent predictor of mortality after adjusting for other clinical risk factors (hazard ratio 1.56, 95% confidence interval 1.35 to 1.80) with prognostic importance equivalent to that of left ventricular ejection fraction. Although the relative risk of LVH did not vary by race or gender, the attributable risk of LVH was greater in blacks and women.

CONCLUSIONS: Clinicians should consider the prognostic importance of LVH when assessing risk in patients with CAD. Because LVH is more common among black and women patients with CAD, it partially accounts for racial and gender differences in survival.

Abbreviations and Acronyms
  BSA
  body surface area
  CAD
  coronary artery disease
  CI
  confidence interval
  HR
  hazard ratio
  IVSTd
  interventricular septal thickness at end-diastole
  LV
  left ventricular
  LVH
  left ventricular hypertrophy
  LVIDd
  left ventricular internal dimension at end-diastole
  LVM
  left ventricular mass
  LVMI
  left ventricular mass index
  PAR
  population attributable risk
  PWTd
  posterior wall thickness at end-diastole
  RR
  relative risk




This article has been cited by other articles:


Home page
CirculationHome page
L. J. Shaw, R. E. Shaw, C. N. B. Merz, R. G. Brindis, L. W. Klein, B. Nallamothu, P. S. Douglas, R. J. Krone, C. R. McKay, P. C. Block, et al.
Impact of Ethnicity and Gender Differences on Angiographic Coronary Artery Disease Prevalence and In-Hospital Mortality in the American College of Cardiology-National Cardiovascular Data Registry
Circulation, April 8, 2008; 117(14): 1787 - 1801.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C. M. Westerhout, M. S. Lauer, S. James, Y. Fu, L. Wallentin, P. W. Armstrong, and for the GUSTO IV ACS Investigators
Electrocardiographic left ventricular hypertrophy in GUSTO IV ACS: an important risk marker of mortality in women
Eur. Heart J., September 1, 2007; 28(17): 2064 - 2069.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. K. Mehta, J. E. Rame, A. Khera, S. A. Murphy, R. M. Canham, R. M. Peshock, J. A. de Lemos, and M. H. Drazner
Left Ventricular Hypertrophy, Subclinical Atherosclerosis, and Inflammation
Hypertension, June 1, 2007; 49(6): 1385 - 1391.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
K. Bibbins-Domingo, G. M. Chertow, L. F. Fried, M. C. Odden, A. B. Newman, S. B. Kritchevsky, T. B. Harris, S. Satterfield, S. R. Cummings, and M. G. Shlipak
Renal function and heart failure risk in older black and white individuals: the health, aging, and body composition study.
Arch Intern Med, July 10, 2006; 166(13): 1396 - 1402.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. J. Rodriguez, F. Lin, R. L. Sacco, Z. Jin, B. Boden-Albala, S. Homma, and M. R. Di Tullio
Prognostic Implications of Left Ventricular Mass Among Hispanics: The Northern Manhattan Study
Hypertension, July 1, 2006; 48(1): 87 - 92.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. N. Bairey Merz, L. J. Shaw, S. E. Reis, V. Bittner, S. F. Kelsey, M. Olson, B. D. Johnson, C. J. Pepine, S. Mankad, B. L. Sharaf, et al.
Insights From the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: Gender Differences in Presentation, Diagnosis, and Outcome With Regard to Gender-Based Pathophysiology of Atherosclerosis and Macrovascular and Microvascular Coronary Disease
J. Am. Coll. Cardiol., February 7, 2006; 47(3_Suppl_S): S21 - S29.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. K. Jacobs
Women, Ischemic Heart Disease, Revascularization, and the Gender Gap: What Are We Missing?
J. Am. Coll. Cardiol., February 7, 2006; 47(3_Suppl_S): S63 - S65.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
L. J. Shaw, R. C. Hendel, M. Cerquiera, J. H. Mieres, N. Alazraki, E. Krawczynska, S. Borges-Neto, J. Maddahi, and C. N. Bairey Merz
Ethnic Differences in the Prognostic Value of Stress Technetium-99m Tetrofosmin Gated Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging
J. Am. Coll. Cardiol., May 3, 2005; 45(9): 1494 - 1504.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. L. Smith, M. G. Shlipak, E. P. Havranek, F. A. Masoudi, W. M. McClellan, J. M. Foody, S. S. Rathore, and H. M. Krumholz
Race and Renal Impairment in Heart Failure: Mortality in Blacks Versus Whites
Circulation, March 15, 2005; 111(10): 1270 - 1277.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. L. Houghton, D. S. Strogatz, M. T. Torosoff, V. E. Smith, S. A. Fein, P. A. Kuhner, E. F. Philbin, and A. A. Carr
African Americans With LVH Demonstrate Depressed Sensitivity of the Coronary Microcirculation to Stimulated Relaxation
Hypertension, September 1, 2003; 42(3): 269 - 276.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement